You are here

CAR-T

Candel Pairs HSV Vectors with Carl June's CAR-T Cells in Solid Tumor Pact

BioSpace

Thu, 10/27/22 - 10:54 am

Candel Therapeutics

Gilead, working to improve cancer cell therapy, partners with California startup

BioPharma Dive

Thu, 10/20/22 - 11:28 pm

Gilead Sciences

Refuge Biotechnologies

Kyverna Files First IND to Leverage CAR-T Therapy for Lupus

BioSpace

Thu, 10/20/22 - 10:32 am

Kyverna Therapeutics

lupus nephritis

Inceptor, Avectas are latest biotechs to take up solid tumor CAR-T challenge

Fierce Biotech

Wed, 10/12/22 - 11:44 pm

Allogene Therapeutics debuts CAR T Together to expand treatment access

Medical Marketing and Media

Wed, 10/12/22 - 10:57 am

Allogene Therapeutics

pharma marketing

Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial

Global Newswire

Thu, 10/6/22 - 07:06 pm

large B cell lymphoma

clinical trials

Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold

Endpoints

Tue, 08/30/22 - 11:50 am

Beam Therapeutics

Gilead hits back at Bristol Myers' Supreme Court petition in CAR-T patent feud

Fierce Pharma

Sun, 08/28/22 - 10:19 pm

Gilead Sciences

Bristol Myers Squibb

Regen BioPharma Develops Novel Means of Using CAR-T cell Immunotherapy to Attack Solid Tumors

Guru Focus

Thu, 08/25/22 - 07:58 pm

Regen Biopharma

cell therapy cancer

Flush with $126M raise, Tessa Therapeutics woos new CEO from Takeda

Endpoints

Mon, 08/22/22 - 10:04 am

Tessa Therapeutics

Thomas Willemsen

Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial

Clinical Trials Arena

Tue, 08/16/22 - 11:12 am

Anixa Biosciences

clinical trials

Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma

BioPharma Dive

Wed, 08/10/22 - 11:34 pm

Bristol Myers Squibb

Multiple Myeloma

Galapagos cleans closet of another 4 programs to make room for CAR-T ambitions

Fierce Biotech

Sun, 08/7/22 - 11:22 pm

ElevateBio, Boston Children’s launch startup to test new approach to ‘off-the-shelf’ cell therapy

BioPharma Dive

Fri, 08/5/22 - 10:36 am

Boston Children's Hospital

It’s official: Roche is a Car-T player

EP Vantage

Wed, 08/3/22 - 10:42 am

Poseida Therapeutics

Celyad gets the go-ahead to resume CAR-T trial for colorectal cancer as FDA lifts hold

Endpoints

Mon, 08/1/22 - 11:54 pm

colorectal cancer

clinical trials

Bristol Myers CAR-T sales rise despite production problems

BioPharma Dive

Wed, 07/27/22 - 06:44 pm

Bristol Myers Squibb

J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion

Fierce Pharma

Wed, 07/27/22 - 10:28 am

Legend scraps early-stage CAR-T for lymphoma 6 weeks after clinical hold lifted

Fierce Biotech

Fri, 07/8/22 - 10:32 am

clinical trials

Amidst Legal Battle, BMS' CAR-T Therapy Scores Second FDA Approval

BioSpace

Mon, 06/27/22 - 06:32 pm

Bristol Myers Squibb

large B-cell lymphoma

Pages